Navigation Links
Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
Date:3/28/2011

$150,000 (other than to replace on substantially similar terms, including as to remuneration and benefits, a person who has ceased to be an employee of any member of the ChemGenex Group);(J)

does any of the following:(aa)

makes any change in the basis or amount of the remuneration of, or otherwise varies in any material respect the employment or appointment arrangements of, any employee or director, other than in the ordinary course of business and consistent with past practice;(bb)

accelerates the rights of any director or employee to compensation or benefits of any kind;(cc)

pays any bonus or pays or provides any termination, retention or retirement payment or other benefit to any director or employee, except as required by law, in accordance with the terms of an agreement disclosed to Cephalon CXS prior to the Announcement Date or in accordance with any entitlement under the terms of any superannuation, provident or retirement scheme in effect as at the Announcement Date; or (dd)

enters into, or makes any amendment to, any deed of indemnity, access and insurance (or similar arrangement) in favour of any director or employee;(K)

does any of the following:(aa)

licenses any of its intellectual property to any person other than a member of the ChemGenex Group;(bb)

enters into any agreement pursuant to which it agrees to undertake any research and development for any person other than a member of the ChemGenex Group; or(cc)

takes a licence of intellectual property of any person other than a member of the ChemGenex Group; or(L)

discloses the existence of any matter described in sub-paragraphs (A) to (K) above, or agrees, offers or authorises, or announces any intention or proposal, to do anything described in sub-paragraphs (A) to (K) above, except to the extent fully and accurately announced by ChemGenex to the ASX prior to the Announcement Date.(v)

ExclusionsNone of paragraphs (i) to (iv) sh
'/>"/>

SOURCE Cephalon, Inc.; ChemGenex Pharmaceuticals Limited
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Cephalon Wins FENTORA Patent Suit Against Watson
2. Cephalon Announces Definitive Agreement to Acquire Gemin X
3. Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010
4. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
5. ImmunGene Announces Multi-Target R&D Collaboration With Cephalon Australia for Interferon Payload Technology
6. Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
7. Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
8. Cephalon to Webcast Investor Day
9. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
10. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
11. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Pharmaceuticals, Inc. (NASDAQ: ISIS ), the leader in ... corporate update in conjunction with its 2013 Annual Meeting of ... p.m. Pacific Time in Carlsbad, CA. ... 2:00 p.m. – 2:10 p.m. Annual Meeting of Stockholders (only ... p.m. – 3:15 p.m. Corporate Presentation – Stanley T. ...
(Date:6/17/2013)... , June 17, 2013 Vanda ... presented additional data today at ENDO 2013, the ... that tasimelteon can entrain (synchronize) both melatonin and ... to reset the master body clock and address ... Disorder (Non-24).  The SET (Safety and Efficacy of ...
(Date:6/17/2013)... 17, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... has filed a preliminary prospectus supplement to its effective shelf ... similar filing with securities regulatory authorities in each of the ... a public offering of its common shares to raise gross ... Company will also grant to the underwriters of the Offering ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
... Reportlinker.com announces that a new market research report ... Global Markets for Catheters http://www.reportlinker.com/p0801348/Global-Markets-for-Catheters.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ...   STUDY GOALS AND OBJECTIVES ... in conducting this study was to determine the present ...
...  Experts from PAREXEL International Corporation (NASDAQ: ... will advise biopharmaceutical companies on how to successfully navigate ... Drug Information Association (DIA) 24th Annual EuroMeeting. The meeting ... Copenhagen, Denmark. Consultants from PAREXEL will be ...
Cached Medicine Technology:Global Markets for Catheters 2Global Markets for Catheters 3Global Markets for Catheters 4Global Markets for Catheters 5Global Markets for Catheters 6Global Markets for Catheters 7Global Markets for Catheters 8Global Markets for Catheters 9Global Markets for Catheters 10Global Markets for Catheters 11Global Markets for Catheters 12Global Markets for Catheters 13Global Markets for Catheters 14Global Markets for Catheters 15Global Markets for Catheters 16PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting 2PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting 3PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting 4
(Date:6/19/2013)... After investing efforts for months in ... formally announced the launch of database integration for the ... latest entry in the list of extraordinary vehicles lined ... redesigned 2012 Nissan NV is all ready to get ... , Provided with two high power capable engines, the ...
(Date:6/19/2013)... Audibel Hearing Center is pleased ... patients, the A2 with Multiflex Tinnitus Technology. Tinnitus ... in the ears. Although bothersome, tinnitus usually isn’t ... , Using their patent-pending Multiflex Tinnitus Technology, the ... sound stimulus that resonates through the patient’s ear. ...
(Date:6/19/2013)... June 19, 2013 According to Vanessa ... abusers called “psychonauts” are creating new designer drugs featuring ... research of published documents and patented formulas. She reported ... & Now on June 4. , “Some of ... They’re never tested on humans. Maybe some of them ...
(Date:6/19/2013)... The Report "Data Center Security Market ... DLP, UTM, IAM, SIEM, DR, ILM); Physical Security ... Advancements, Forecasts & Analysis (2013-2018)", defines and segments ... sub-segments with in-depth analysis and forecasting of revenues. ... market with insights into trends, opportunities, and challenges. ...
(Date:6/19/2013)... Tewkesbury, UK (PRWEB) June 19, 2013 ... solutions, is sponsoring today's event, at which it will ... issues, as well as giving further insight into its ... gathering for IT & business professionals specialising in IDM ... wide range of markets including the public sector, banking, ...
Breaking Medicine News(10 mins):Health News:Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV 2Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 2Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 4
... a study by a researcher from University of California, ... are found not in the similarity of the genome ... them. ,Researcher had described genetic differences between the ... that is also expressed in brain cells associated with ...
... be available in pharmacies as over the counter drug ... women to avoid unnecessary pregnancy. The decision was announced// ... the governments decision the minister said, "The step has ... such situations as unprotected sexual exposure, contraceptive accident or ...
... from the Steno Diabetes Center, Denmark has found ... taking //antihypertensive drugs, reduced the chances of developing ... protein in urine of these patients. ... prone to kidney diseases. Supplementation of Spironolactone has ...
... of AIDS and 35 people have died of it in the ... at more than 100 and more than 2,000 full-blown AIDS cases. ... very low awareness in Jharkand. ,Jharkand plans to open ... of HIV spread. This new attempt to open the condom booths ...
... losing their eyesight later in life than non-smokers, says a ... UK with age-related macular degeneration (AMD). Of these, an ... smoking.// ,AMD usually develops after a person reaches ... of the eye. A report by AMD Alliance UK, based ...
... The lancet says that a combination of newer ... procedures.// ,Hypertension is the most important preventable ... the benefits of anti-hypertensive drugs for prevention of ... no individual trial using standard diuretic or Beta-blocker ...
Cached Medicine News:Health News:Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug 2
Blunt Weitlaner Retractor....
Weitlaner Beckmann retractor, sharp prongs, SS....
Baby Weitlaner retractor, blunt, 4"....
Scoville sharp curette, 10, straight, scoop size 4 x 10 mm....
Medicine Products: